KPMG in association with Venture Valuation
This analysis is aimed at helping entrepreneurs to choose the best possible spot to set up Biotechnology business in EU. The report compares leading EU Life Science Clusters: France, Germany, Ireland, the Netherlands, Switzerland and the UK. Among others the following factors are taken into account: structure of a country Life Science industry, product pipelines, insights into existing regional and global headquarters, financing opportunities, tax optimization, R&D incentives, IP management, macroeconomic performance, general business environment, flexibility of labour regulations and the cost of doing business.
Site-Selection-for-Life-Sciences-Companies-O-201310.pdf